Advances in Oral Coagulants.
This article reviews current and future treatment practices concerning oral anticoagulants. In the second decade of the 21st millennium clinicians can finally treat thrombotic disease with long-awaited new oral anticoagulant medications. In addition, improvements have been made in managing warfarin, the traditional but far from obsolete medication. The first part of this review will cover current advances with warfarin treatment. The second portion will discuss specific active coagulation factor inhibitors, the new oral anticoagulants.
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, and Children's Hospital of Philadelphia and the Philadelphia VA Medical Center.
Eleanor S
ES
Pollak
apixaban; dabigatran; oral anticoagulants; pharmacogenetics; rivaroxaban; warfarin
Thromb Haemost. 1984 Dec 29;52(3):336-42
6531756
Am J Emerg Med. 2012 Nov;30(9):2046-54
22795419
Int J Gynaecol Obstet. 2002 Sep;78(3):221-5
12384267
Adv Enzymol Relat Areas Mol Biol. 1979;48:277-318
367103
Am Fam Physician. 1999 Feb 1;59(3):635-46
10029789
Thromb Haemost. 2010 Jun;103(6):1116-27
20352166
Thromb Haemost. 2012 Sep;108(3):476-84
22740145
Am J Hematol. 2012 May;87 Suppl 1:S141-5
22473649
N Engl J Med. 2011 Mar 3;364(9):806-17
21309657
Adv Ther. 2012 Jun;29(6):491-507
22684583
N Engl J Med. 2009 Sep 17;361(12):1139-51
19717844
Clin Pharmacol Ther. 2011 Oct;90(4):625-9
21900891
Thromb Res. 2012 Oct;130 Suppl 1:S41-3
23026659
Circulation. 1959 Jan;19(1):97-107
13619027
J Thromb Thrombolysis. 2012 Nov;34(4):437-45
22865256
Expert Opin Investig Drugs. 2012 Aug;21(8):1235-9
22690880
Expert Rev Cardiovasc Ther. 2012 Feb;10(2):143-9
22292869
Clin Pharmacol Ther. 2008 Sep;84(3):326-31
18305455
N Engl J Med. 2011 Sep 8;365(10):883-91
21830957
Nat Rev Cardiol. 2012 Feb 28;9(7):385-91
22371104
Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1471-80
23253272
Fundam Clin Pharmacol. 2012 Feb;26(1):47-53
21883447
Nature. 2004 Feb 5;427(6974):541-4
14765195